Sign inJoin waitlistJoin the waitlist

Marta Penas-Prado

Physician · Clinical Center at the National Institutes of Health

Credentials: · · ·

History

Clinical Center at the National Institutes of Health
Present

University of Texas M D Anderson Cancer Center
Neurology

Research

The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings
Annals of Oncology · 2013 · 241 citations
Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial
Clinical Cancer Research · 2021 · 229 citations
An independently validated nomogram for individualized estimation of survival among patients with newly diagnosed glioblastoma: NRG Oncology RTOG 0525 and 0825
Neuro-Oncology · 2017 · 167 citations

EB
Eric Burton
19 papers
Brett Theeler
18 papers · 1 as a fellow
Kenneth Aldape
18 papers
Anna Choi
17 papers
Heather Leeper
16 papers · 2 as a fellow
John de Groot
16 papers
AM
Anita Mahajan
13 papers
MP
Marissa Panzer
12 papers
Byram Ozer
9 papers
Gregory Fuller
9 papers
Jason Levine
9 papers
Paul Brown
9 papers

Grants

Development of New Treatments for Rare CNS Tumors
National Cancer Institute · ZIA
Contact PI · $855.9K · Division of Basic Sciences - Nci

Clinical trials

Lacosamide in Preventing Seizures in Participants With Malignant Glioma
Principal investigator · Terminated
M.D. Anderson Cancer Center
2012–2017
Dose-Dense Temozolomide + Lapatinib for Recurrent Ependymoma
Principal investigator · Completed · Phase 2
National Institutes of Health Clinical Center (CC)
2009–2018
Vorinostat, Isotretinoin and Temozolomide in Adults With Recurrent Glioblastoma Multiforme (GBM)
Principal investigator · Terminated · Phase 1, Phase 2
M.D. Anderson Cancer Center
2007–2020
Temozolomide Alone or in Combination With Thalidomide and/or Isotretinoin and/or Celecoxib in Treating Patients Who Have Undergone Radiation Therapy for Glioblastoma Multiforme
Study chair · Completed · Phase 2
M.D. Anderson Cancer Center
2005–2014